Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thyroid function in the intensive care unit setting.

K D Burman1, L Wartofsky

  • 1Department of Medicine, Uniformed Services University of the Health Sciences Center, Bethesda, Maryland, USA.

Critical Care Clinics
|February 24, 2001
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel biomarker <i>SYT12</i> may contribute to predicting papillary thyroid cancer outcomes.

Future science OA·2017
Same author

A 2013 European survey of clinical practice patterns in the management of Graves' disease.

Clinical endocrinology·2015
Same author

Reprint of: policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al.

Hormones and behavior·2013
Same author

Reprint of: policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich, et al.

Frontiers in neuroendocrinology·2013
Same author

Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al.

Andrology·2013
Same author

Policy decisions on endocrine disruptors should be based on science across disciplines: a response to Dietrich et al.

Hormone research in paediatrics·2013
Same journal

Critical Care and Contagion: Evolving Frontiers of Infectious Diseases in the Modern Intensive Care Unit.

Critical care clinics·2026
Same journal

Advances and Challenges in Sepsis Care in Low-Resource Settings.

Critical care clinics·2026
Same journal

The Respiratory Triple Pandemic in the Intensive Care Unit: Epidemiology, Clinical Features and Management of COVID-19, Influenza and Respiratory Syncytial Virus.

Critical care clinics·2026
Same journal

Antibiotic Stewardship for the Intensivist.

Critical care clinics·2026
Same journal

Infection Prevention and Control in the Intensive Care Unit.

Critical care clinics·2026
Same journal

Antibiotic Considerations in the Critically Ill: Empiric Choices and Dosing.

Critical care clinics·2026
See all related articles

Current evidence does not support using thyroid hormones like thyroxine (T4) or triiodothyronine (T3) for nonthyroidal illness. More research is needed to determine benefits versus risks for most patients.

Area of Science:

  • Endocrinology
  • Internal Medicine

Background:

  • Nonthyroidal illness (NTI) is characterized by altered thyroid hormone levels.
  • The role of thyroid hormone replacement in NTI remains controversial.

Purpose of the Study:

  • To evaluate the current evidence for the utility of T4 and T3 administration in patients with NTI.
  • To identify the need for further research in this area.

Main Methods:

  • Systematic review of published studies on T4 and T3 administration in NTI.
  • Analysis of clinical trial data and expert opinions.

Main Results:

  • No convincing published evidence supports the use of T4 or T3 in NTI.
  • Existing studies are limited by disease-specific applicability and study design.

Related Experiment Videos

Conclusions:

  • Further large-scale prospective studies are required to definitively resolve the issue of T3 treatment in NTI.
  • Thyroid hormone administration in NTI should be approached cautiously, with benefits weighed against risks, as indications are limited.